Save time and get answers to complex questions with AI chat
Somatuline generic name?Patent expiration date of guselkumab?Defense strategy against generic in niche market?Chlorpheniramine cost?Alogliptin benz cost?
See the DrugPatentWatch profile for polivy
Polivy (polatuzumab vedotin) most commonly reported adverse reactions (occurring in about 20% or more of patients) when used with bendamustine and rituximab for relapsed/refractory DLBCL include: - Neutropenia - Anemia - Thrombocytopenia - Fatigue - Diarrhea - Constipation - Decreased appetite - Nausea - Peripheral neuropathy - Fever - Infection If you want, I can pull the exact percentages from the FDA label or give you info for other regimens (e.g., monotherapy or different combinations).
Other Questions About Polivy :